Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

A Systematic Review and Meta-Analysis of Cardio-Vascular Side Effects with Fostamatinib a Spleen Tyrosine Kinase Inhibitor

Muhammad Zain Farooq, MD MBBS, Prasanth Lingamaneni, Saira Farid, MD, Muhammad Saad Farooq, MBBS, Ishaan Vohra, MD, Asim Tameez ud din, MD, Ankit Mangla, MBBS,MD

Blood (2019) 134 (Supplement_1): 3465.

https://doi.org/10.1182/blood-2019-132151

Published: 2019

Journal Articles

Value of Pre-Procedural Lymphocyte-to-Monocyte Ratio for Predicting New Cerebral Ischemic and Haemorrhagic Lesions Observed after Transcatheter Aortic Valve Implantation: A Pilot Study

Tom Denimal, Fanny Lassalle, PharmD, Nicolas Debry, MD, Antoine Rauch, MD PhD, Flavien Vincent, MD PhD, Bart Staels, PharmD, PhD, André Vincentelli, MD PhD, Sophie Susen, MD PhD, Eric Van Belle, MD PhD, Annabelle Dupont, PharmD, PhD

Blood (2019) 134 (Supplement_1): 3653.

https://doi.org/10.1182/blood-2019-126466

Published: 2019

Journal Articles

Outcomes, Causes of Discontinuation and Mutation Profile of Patients with Mantle Cell Lymphoma Who Progressed on Acalabrutinib

Preetesh Jain, MBBS, MDDM, PhD, Rashmi Kanagal-Shamanna, MD, Shaojun Zhang, PhD, Chi Young Ok, MD, Makhdum Ahmed, MD PhD MPH, Diana Nava, Maria Badillo, Krystle Nomie, PhD, Keyur Patel, MD PhD, Hun Ju Lee, MD, F. B. Hagemeister, MD, Luis Fayad, MD, Loretta J. Nastoupil, MD, L. Jeffrey Medeiros, MD, Sattva S. Neelapu, MD, Jorge Enrique Romaguera, Nathan H. Fowler, MD, Linghua Wang, PhD, Michael Wang, MD

Blood (2018) 132 (Supplement 1): 4151.

https://doi.org/10.1182/blood-2018-99-115179

Published: 2018

Journal Articles

Long-Term Follow-up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma

Blood (2018) 132 (Supplement 1): 2876.

https://doi.org/10.1182/blood-2018-99-110327

Published: 2018

Journal Articles

Efficacy and Safety of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in the Phase 2 ACE-LY-004 Study

Blood (2017) 130 (Supplement 1): 155.

https://doi.org/10.1182/blood.V130.Suppl_1.155.155

Published: 2017

Journal Articles

Mice Lacking Platelet TGF-β1 Are Protected from Aortic Stenosis Progression

Rohan Varshney, PhD, Brennah Murphy, Shahrouz Ghafoory, PhD, Tyler Robison, Sean Woolington, Jasimuddin Ahamed, PhD

Blood (2017) 130 (Supplement 1): 551.

https://doi.org/10.1182/blood.V130.Suppl_1.551.551

Published: 2017

Journal Articles

Pharmacokinetics (PK) and Pharmacodynamics (PD), Safety and Tolerability of a Single-Dose Oral Solution of Dabigatran Etexilate Given after Standard Anticoagulant Therapy in Children from Birth to Less Than One Year Old, with Venous Thromboembolism

Jacqueline ML Halton, MD, Anne-Caroline Picard, Ruth Harper, Fenglei Huang, Martina Brueckmann, MD, Savion Gropper, MD, Hugo Maas, Igor Tartakovsky, MD, Ildar Nurmeev, Lesley G Mitchell, Leonardo R. Brandão, MD MSc, Manuela Albisetti, MD

Blood (2016) 128 (22): 1441.

https://doi.org/10.1182/blood.V128.22.1441.1441

Published: 2016

Journal Articles

VWF Multimer Quantitation for Assessment of Cardiac Lesion Severity and Bleeding Risk

Justin Bryan, BS, Christopher Austin, MD, Colleen Thomas, Robert E. Safford, MD PhD, Dong Chen, MD PhD, Joseph Blackshear, MD

Blood (2016) 128 (22): 2588.

https://doi.org/10.1182/blood.V128.22.2588.2588

Published: 2016

Journal Articles

Diastolic but Not Systolic Heart Failure Is Associated with Multiple Abnormalities on Platelet Aggregation Testing

Dharmesh Gopalakrishnan, MD, Heesun J Rogers, MD PhD, Paul Elson, PhD, Keith R. McCrae, MD

Blood (2015) 126 (23): 1079.

https://doi.org/10.1182/blood.V126.23.1079.1079

Published: 2015

Journal Articles

Decreased Platelet Thrombus Size, Due to a Heightened Proteolysis of VWF By ADAMTS13, Is Quickly Restored after Valve Replacement in Aortic Stenosis Patients

Hideo Yagi, MD PhD, Masaki Hayakawa, MD, Naoko Yamaguchi, Keigo Yamashita, MD, Shigeki Taniguchi, MD PhD, Masanori Matsumoto, MD PhD, Kazuo Tsubaki, MD PhD, Yoshihiro Fujimura, MD PhD

Blood (2014) 124 (21): 2857.

https://doi.org/10.1182/blood.V124.21.2857.2857

Published: 2014

Journal Articles

Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac Procedures

Antoine Rauch, MD, Eric Van Belle, MD PhD, André Vincentelli, MD PhD, Paulette Legendre, Emmanuelle Jeanpierre, Christopher Hurt, MD, Carlo Banfi, MD, Claudine Caron, Francis Juthier, MD PhD, Ahmed Elkalioubie, MDPhD, Natacha Rousse, MD, Delphine Corseaux, PhD, Christophe Zawadzki, PhD, Giulia Chinetti, PhD, Brigitte Jude, MD PhD, Jenny Goudemand, MD PhD, Bart Staels, Peter J. Lenting, PhD, Sophie Susen, MDPhD

Blood (2014) 124 (21): 474.

https://doi.org/10.1182/blood.V124.21.474.474

Published: 2014

Journal Articles

Systemic Activation of Platelet-Derived TGF-β1 Leads to Increased Smad2/3 Phosphorylation in Circulating Leukocytes and Platelet-Leukocyte Aggregates in a Mouse Model of Aortic Valve Stenosis

Wei Wang, MD, Nathalie Burg, MD, Spandana Vootukuri, MS, Barry S. Coller, MD

Blood (2014) 124 (21): 2756.

https://doi.org/10.1182/blood.V124.21.2756.2756

Published: 2014

Journal Articles

Acquired Von Willebrand Syndrome Associated with B Cell Chronic Lymphoproliferative Disorders. Results from a Prospective Observational Study

Jean Baptiste Rabec, MD, Philippe Gautier, MD, Xavier Troussard, MD PhD, Anne Claire Gac, MD, Sylvain Chantepie, MD, Margareth Macro, MD, Stephane Cheze, MD, Khaled Benabed, MD, Damaj Gandhi, MDPhD, Annie Borel Derlon, MDPhD, Yohann Repesse, PhD

Blood (2014) 124 (21): 1509.

https://doi.org/10.1182/blood.V124.21.1509.1509

Published: 2014

Journal Articles

Utility of Various Von Willebrant Factor Laboratory Tests in Assessment of Acquired Von Willebrant Syndrome in Patients with Aortic Stenosis

Deepti M. Warad, M.B.B.S., Rachel Leger, BA, Colleen S Thomas, MS, Ewa M. Wysokinska, MD, Matthew Auton, PhD, Joseph L Blackshear, MD, Dong Chen, MD, PhD

Blood (2014) 124 (21): 1517.

https://doi.org/10.1182/blood.V124.21.1517.1517

Published: 2014

Journal Articles

Acquired Von Willebrand Disease – To Treat Or Not To Treat The Inhibitor?

Surbhi Shah, MBBS, Mark Reding

Blood (2013) 122 (21): 4744.

https://doi.org/10.1182/blood.V122.21.4744.4744

Published: 2013

Journal Articles

Spectrum Of The Acquired Von Willebrand Syndrome In a Large Cohort Of Patients Diagnosed In a Single Institution

Ulrich Budde, MD, Rita Dittmer, Hala El- Abd Müller, Hanna Schaeper, Sonja Schneppenheim, MD

Blood (2013) 122 (21): 3607.

https://doi.org/10.1182/blood.V122.21.3607.3607

Published: 2013

Journal Articles

Laboratory Predictors Of Loss Of High Molecular Weight Multimers In Patients With Cardiovascular Disease-Associated Acquired Von Willebrand Syndrom

Ewa M. Wysokinska, MD, Dong Chen, M.D., Ph.D., Joseph L Blackshear, MD

Blood (2013) 122 (21): 335.

https://doi.org/10.1182/blood.V122.21.335.335

Published: 2013

Journal Articles

A Scoring System to Predict the Likelihood of Acquired Von Willebrand Syndrome (AVWS) in Patients with Cardiovascular Diseases

Katherine M. Duello, MD, Thomas S Colleen, MS, Dong Chen, MD, PhD, Joseph L Blackshear, MD

Blood (2012) 120 (21): 3377.

https://doi.org/10.1182/blood.V120.21.3377.3377

Published: 2012

Journal Articles

Severity of the Loss of High Molecular Weight Multimers Is Associated with Heyde Syndrome in Patients with Severe Aortic Stenosis.

Ewa M. Wysokinska, MD, Katherine M. Duello, MD, Joseph L Blackshear, MD, Mark E. Stark, M.D., Dong Chen, MD, PhD

Blood (2012) 120 (21): 2230.

https://doi.org/10.1182/blood.V120.21.2230.2230

Published: 2012

Journal Articles

Changes in Plasma TGF-β1 Levels in a Murine Model of Aortic Stenosis (Surgical Constriction of the Ascending Aorta) in C57Bl/6 (wild-type) Mice and Mice with a Targeted Deletion of Platelet TGF-β1

Wei Wang, MD, Alexander Meyer, Barry S. Coller, MD, Jasimuddin Ahamed, PhD

Blood (2012) 120 (21): 1065.

https://doi.org/10.1182/blood.V120.21.1065.1065

Published: 2012

NARROW

A Systematic Review and Meta-Analysis of Cardio-Vascular Side Effects with Fostamatinib a Spleen Tyrosine Kinase Inhibitor

Value of Pre-Procedural Lymphocyte-to-Monocyte Ratio for Predicting New Cerebral Ischemic and Haemorrhagic Lesions Observed after Transcatheter Aortic Valve Implantation: A Pilot Study

Outcomes, Causes of Discontinuation and Mutation Profile of Patients with Mantle Cell Lymphoma Who Progressed on Acalabrutinib

Long-Term Follow-up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma

Efficacy and Safety of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in the Phase 2 ACE-LY-004 Study

Mice Lacking Platelet TGF-β1 Are Protected from Aortic Stenosis Progression

Pharmacokinetics (PK) and Pharmacodynamics (PD), Safety and Tolerability of a Single-Dose Oral Solution of Dabigatran Etexilate Given after Standard Anticoagulant Therapy in Children from Birth to Less Than One Year Old, with Venous Thromboembolism

VWF Multimer Quantitation for Assessment of Cardiac Lesion Severity and Bleeding Risk

Diastolic but Not Systolic Heart Failure Is Associated with Multiple Abnormalities on Platelet Aggregation Testing

Decreased Platelet Thrombus Size, Due to a Heightened Proteolysis of VWF By ADAMTS13, Is Quickly Restored after Valve Replacement in Aortic Stenosis Patients

Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac Procedures

Systemic Activation of Platelet-Derived TGF-β1 Leads to Increased Smad2/3 Phosphorylation in Circulating Leukocytes and Platelet-Leukocyte Aggregates in a Mouse Model of Aortic Valve Stenosis

Acquired Von Willebrand Syndrome Associated with B Cell Chronic Lymphoproliferative Disorders. Results from a Prospective Observational Study

Utility of Various Von Willebrant Factor Laboratory Tests in Assessment of Acquired Von Willebrant Syndrome in Patients with Aortic Stenosis

Acquired Von Willebrand Disease – To Treat Or Not To Treat The Inhibitor?

Spectrum Of The Acquired Von Willebrand Syndrome In a Large Cohort Of Patients Diagnosed In a Single Institution

Laboratory Predictors Of Loss Of High Molecular Weight Multimers In Patients With Cardiovascular Disease-Associated Acquired Von Willebrand Syndrom

A Scoring System to Predict the Likelihood of Acquired Von Willebrand Syndrome (AVWS) in Patients with Cardiovascular Diseases

Severity of the Loss of High Molecular Weight Multimers Is Associated with Heyde Syndrome in Patients with Severe Aortic Stenosis.

Changes in Plasma TGF-β1 Levels in a Murine Model of Aortic Stenosis (Surgical Constriction of the Ascending Aorta) in C57Bl/6 (wild-type) Mice and Mice with a Targeted Deletion of Platelet TGF-β1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only